Skip to main content

stock

RNTX · Rein Therapeutics, Inc.

What Rein Therapeutics, Inc. reports to the SEC, read from its filings.

Open in the app

Price

The live RNTX price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on RNTX.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Pharmaceutical Preparations (SIC 2834)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
86,267,032 as of 2026-08-12 (XBRL frame CY2026Q2I)

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
—
Operating
—
Net
—

Returns

ROE
-90.2%
ROA
-75.5%

Health

Current ratio
4.3x
Debt/equity
—

Deep value

NCAV
$30.68M
NCAV per share
$0.36
Price/NCAV
Locked
NNWC
-$2.23M
NNWC per share
-$0.03
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenueGross profit (not reported by this company)Operating incomeNet incomeFiling
2026-06-30$0—Gross profit: unreported by this company.-$6.08M-$6.38M
10-Q filed 2026-08-14
2026-03-31$0—Gross profit: unreported by this company.-$5.23M-$5.84M
10-Q filed 2026-08-14
Assembled from more than one filing; the filing above is only the newest of them.
2025-12-31$0—Gross profit: unreported by this company.-$32.66M-$32.00M
DEF 14A filed 2026-06-08
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
Assembled from more than one filing; the filing above is only the newest of them.
2025-09-30$0—Gross profit: unreported by this company.-$5.49M-$5.58M
10-Q filed 2025-11-14
2025-06-30$0—Gross profit: unreported by this company.-$6.87M-$6.82M
10-Q filed 2026-08-14
2025-03-31$0—Gross profit: unreported by this company.-$5.61M-$5.50M
10-Q filed 2026-08-14
Assembled from more than one filing; the filing above is only the newest of them.
2024-12-31$0—Gross profit: unreported by this company.-$42.80M-$41.00M
DEF 14A filed 2026-06-08
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
Assembled from more than one filing; the filing above is only the newest of them.
2024-09-30$0—Gross profit: unreported by this company.-$6.07M-$5.85M
10-Q filed 2025-11-14
Assets
$65.97M
Equity
$55.20M

Balance as of 2026-06-30.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2025-12-31$0-$50.63M-$49.90M—
2024-12-31$0-$65.11M-$62.90M—
2023-12-31$0-$16.28M-$15.70M—
2022-12-31$0-$27.65M-$27.33M—
2021-12-31$0-$26.61M-$26.16M-$23.91M
2020-12-31$0-$20.50M-$27.33M-$20.48M
2019-12-31$0-$29.96M-$29.37M-$26.63M
2018-12-31$0-$31.90M-$31.55M-$32.35M
2017-12-31$0-$23.01M-$22.60M-$20.67M
2016-12-31$0-$18.17M-$18.12M—

Company filings

Insiders, politicians and funds

Insider trades, last 90 days

No insider buys or sales filed in the last 90 days.

Politician trades, last 90 days

Funds

News

Stories that named RNTX, and the market events around them.

Sign in to see this

Board

Recent signals

Signals open up here once a member has posted about RNTX.

Signals are informational.

Posts · 0

No posts yet.

Be the first to say something about RNTX.

nakagai

Signals on RNTX come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the RNTX board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.

Rein Therapeutics, Inc. (RNTX): SEC filings, financials and insider trades · Nakagai